Drug Shortage Report for LOVENOX
Report ID | 138194 |
Drug Identification Number | 02378426 |
Brand name | LOVENOX |
Common or Proper name | Lovenox |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ENOXAPARIN SODIUM |
Strength(s) | 60MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 10 |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-12-20 |
Actual start date | |
Estimated end date | 2022-01-31 |
Actual end date | 2022-01-13 |
Shortage status | Resolved |
Updated date | 2022-01-14 |
Company comments | Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.